Caplight Directory>Investors>Japan Agency for Medical Research and Development>Amed-go-jp


Japan Agency for Medical Research and Development

Japan Agency for Medical Research and Development

Tokyoamed.go.jp

Overview

A Japanese government funding agency established in 2015 to promote integrated medical research and development, from basic research to practical applications. It aims to accelerate the translation of research into healthcare solutions by consolidating R&D budgets from multiple ministries and providing streamlined support for projects in areas like regenerative medicine, rare diseases, infectious diseases, and oncology.

Portfolio Companies

8

Website

amed.go.jp

Investments

CompanyDateStageLead
Surv BioPharma Inc.Dec 2025GrantCo-investor
Celaid TherapeuticsOct 2025Series BCo-investor
株式会社fcuroJul 2025GrantLead
AvenCellJun 2025GrantCo-investor
RegCell, Inc.Mar 2025GrantCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTokyo
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.